topics celltrion 
Fish & Richardson Trademark & Copyright Thoughts
FEBRUARY 7, 2022
and Celltrion, Inc. Both Apotex and Celltrion moved for joinder with Mylan’s instituted petitions. Celltrion also filed a PGR petition against an additional Regeneron patent related to aflibercept in September 2021, which remains pending. Institution Reviewability.
Fish & Richardson Trademark & Copyright Thoughts
JANUARY 11, 2022
Herzuma ® (Celltrion/ Teva). Truxima ® (Celltrion/Teva). Celltrion). Amgen is also the most common BPCIA defendant (with 8 cases), while Celltrion (defendant in 7 cases) and Sandoz (defendant in 6 cases) are not far behind. January 18, 2019. April 15, 2020. 15% off Herceptin ®. Herceptin ® (Roche / Genentech). Genentech).
Expert insights. Personalized for you.
52 
Let's personalize your content